How ENTOD’s Year-Long Milestones have contributed to the growth of the Pharmaceutical Industry
● “ENTOD received an approval from the DCGI to start phase 3 clinical trials for 0.05% low-dose atropine eye drops …
Dr. T S Kler Padma Bhushan Awardee
MD, DM, MRCP, FRCP(U.K), FACC, D.Sc
Chairman – Fortis Heart Institute Gurugram
Precautions to avoid Corona Virus: